Chicago Research Center, Inc.

Chicago, Illinois 60634

3 studies enrolling now · 16 studies all time

What they study most

Diabetes Mellitus, Type 2, Diabetic Neuropathy, Painful, Fibromyalgia, Hypertension, Insomnia, Major Depressive Disorder, Major Depressive Disorder (MDD), OSA, Obesity, Obstructive Sleep Apnea, Obstructive Sleep Apnoea, Overweight

Studies at this site

• AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea — Recruiting now
• A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide — Starting soon
• Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients — Completed
• A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia — Completed
• Effect of KYG0395 on Primary Dysmenorrhea — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) — Completed
• Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
• Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD — Completed
• A Study of Intermittent Doses of CERC-301 in MDD — Completed
• Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers — Completed
• A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus — Completed
• A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder — Completed